Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation

Area of Science:

• Cardiology
• Transplantation Immunology
• Vascular Biology

Background:

• Cardiac allograft vasculopathy (CAV) is a major cause of long-term heart transplant failure, affecting nearly one-third of patients within 5 years.
• CAV contributes significantly to mortality, accounting for 1 in 8 deaths beyond the first year post-transplant.
• The condition involves abnormal vascular fibroproliferation driven by immune and non-immune insults leading to endothelial inflammation, injury, and dysfunction.

Purpose of the Study:

• To highlight the critical challenges posed by cardiac allograft vasculopathy (CAV) in heart transplantation.
• To discuss current limitations in CAV surveillance and emerging diagnostic investigations.
• To review evolving treatment strategies and emphasize the importance of prevention for long-term graft survival.

Main Methods:

• Review of current literature on cardiac allograft vasculopathy (CAV) pathophysiology, surveillance, and treatment.
• Discussion of emerging diagnostic modalities including myocardial and coronary blood flow quantification and intracoronary imaging.
• Analysis of the role of newer immunosuppressive agents, such as mammalian target of rapamycin inhibitors, in managing CAV.

Main Results:

• Cardiac allograft vasculopathy (CAV) affects a substantial proportion of heart transplant recipients, leading to significant morbidity and mortality.
• Existing surveillance methods for CAV have limitations in detecting early disease progression.
• Newer immunosuppressive agents show promise in delaying CAV progression, though optimal usage requires further study.

Conclusions:

• Cardiac allograft vasculopathy (CAV) remains a significant barrier to long-term heart transplant survival, necessitating improved understanding and management.
• Enhanced surveillance techniques and targeted therapies are essential to combat the detrimental effects of CAV.
• Further research into CAV pathophysiology is critical for developing effective prevention and treatment strategies to improve patient outcomes.